Recently, a genome-wide association study has identified genetic variants that influence white matter microstructure in the brain. White matter was […]
Researchers have harnessed the power of genome-wide sequencing and functional profiling of immune cells to understand how genetic variants can […]
A study published in Scientific Reports, has identified six significant oral cancer associated genes through differential analysis. Oral cancer Oral […]
A recent study published in the Journal of the National Cancer Institute has discovered three genetic variants linked to an […]
Heart disease is one of the leading causes of death globally. Two of the most common forms of heart disease […]
Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.
The current COVID-19 pandemic has revealed that increased age and the presence of co-existing health conditions, such as cancer, cardiovascular, […]
Endometriosis affects 1 in 10 women worldwide. The current therapies for this condition are limited and tend to focus on […]
Giles Yeo is a Principal Research Associate at MRC Metabolic Diseases Unit and the Scientific Director of the Genomics/Transcriptomics Core […]
In a recent study, researchers identified 11 rare genetic variants related to Alzheimer’s disease through high-risk pedigree studies. Alzheimer’s disease […]
